BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 11005237)

  • 1. Selective expression of lysyl oxidase (LOX) in the stromal reactions of broncho-pulmonary carcinomas.
    Peyrol S; Galateau-Salle F; Raccurt M; Gleyzal C; Sommer P
    Histol Histopathol; 2000 Oct; 15(4):1127-35. PubMed ID: 11005237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The lysyl oxidase LOX is absent in basal and squamous cell carcinomas and its knockdown induces an invading phenotype in a skin equivalent model.
    Bouez C; Reynaud C; Noblesse E; Thépot A; Gleyzal C; Kanitakis J; Perrier E; Damour O; Sommer P
    Clin Cancer Res; 2006 Mar; 12(5):1463-9. PubMed ID: 16533769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lysyl oxidase gene expression in the stromal reaction to in situ and invasive ductal breast carcinoma.
    Peyrol S; Raccurt M; Gerard F; Gleyzal C; Grimaud JA; Sommer P
    Am J Pathol; 1997 Feb; 150(2):497-507. PubMed ID: 9033266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lysyl oxidase-like protein localizes to sites of de novo fibrinogenesis in fibrosis and in the early stromal reaction of ductal breast carcinomas.
    Decitre M; Gleyzal C; Raccurt M; Peyrol S; Aubert-Foucher E; Csiszar K; Sommer P
    Lab Invest; 1998 Feb; 78(2):143-51. PubMed ID: 9484712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repression of BCL2 by the tumor suppressor activity of the lysyl oxidase propeptide inhibits transformed phenotype of lung and pancreatic cancer cells.
    Wu M; Min C; Wang X; Yu Z; Kirsch KH; Trackman PC; Sonenshein GE
    Cancer Res; 2007 Jul; 67(13):6278-85. PubMed ID: 17616686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lysyl oxidase expression in bronchogenic carcinoma.
    Woznick AR; Braddock AL; Dulai M; Seymour ML; Callahan RE; Welsh RJ; Chmielewski GW; Zelenock GB; Shanley CJ
    Am J Surg; 2005 Mar; 189(3):297-301. PubMed ID: 15792754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lysyl oxidase: a lung adenocarcinoma biomarker of invasion and survival.
    Wilgus ML; Borczuk AC; Stoopler M; Ginsburg M; Gorenstein L; Sonett JR; Powell CA
    Cancer; 2011 May; 117(10):2186-91. PubMed ID: 21523732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The tumor suppressor activity of the lysyl oxidase propeptide reverses the invasive phenotype of Her-2/neu-driven breast cancer.
    Min C; Kirsch KH; Zhao Y; Jeay S; Palamakumbura AH; Trackman PC; Sonenshein GE
    Cancer Res; 2007 Feb; 67(3):1105-12. PubMed ID: 17283144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A molecular role for lysyl oxidase in breast cancer invasion.
    Kirschmann DA; Seftor EA; Fong SF; Nieva DR; Sullivan CM; Edwards EM; Sommer P; Csiszar K; Hendrix MJ
    Cancer Res; 2002 Aug; 62(15):4478-83. PubMed ID: 12154058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Matrix cross-linking lysyl oxidases are induced in response to myocardial infarction and promote cardiac dysfunction.
    González-Santamaría J; Villalba M; Busnadiego O; López-Olañeta MM; Sandoval P; Snabel J; López-Cabrera M; Erler JT; Hanemaaijer R; Lara-Pezzi E; Rodríguez-Pascual F
    Cardiovasc Res; 2016 Jan; 109(1):67-78. PubMed ID: 26260798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recognition of lysyl oxidase as a potential predictive biomarker for oral squamous cell carcinoma: an immunohistochemical study.
    Bhanu U; Natarajan S; Manaktala N; Boaz K; Joshi R; Deepak S; Kp N; Lewis A
    Minerva Stomatol; 2020 Dec; 69(6):360-369. PubMed ID: 32744444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uncovering the role of nuclear Lysyl oxidase (LOX) in advanced high grade serous ovarian cancer.
    De Donato M; Petrillo M; Martinelli E; Filippetti F; Zannoni GF; Scambia G; Gallo D
    Gynecol Oncol; 2017 Jul; 146(1):170-178. PubMed ID: 28495238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlations of lysyl oxidase with MMP2/MMP9 expression and its prognostic value in non-small cell lung cancer.
    Liu J; Ping W; Zu Y; Sun W
    Int J Clin Exp Pathol; 2014; 7(9):6040-7. PubMed ID: 25337249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paradoxical roles for lysyl oxidases in cancer--a prospect.
    Payne SL; Hendrix MJ; Kirschmann DA
    J Cell Biochem; 2007 Aug; 101(6):1338-54. PubMed ID: 17471532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lysyl oxidase activates cancer stromal cells and promotes gastric cancer progression: quantum dot-based identification of biomarkers in cancer stromal cells.
    Peng C; Liu J; Yang G; Li Y
    Int J Nanomedicine; 2018; 13():161-174. PubMed ID: 29343955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lysyl oxidase-like and lysyl oxidase are present in the dermis and epidermis of a skin equivalent and in human skin and are associated to elastic fibers.
    Noblesse E; Cenizo V; Bouez C; Borel A; Gleyzal C; Peyrol S; Jacob MP; Sommer P; Damour O
    J Invest Dermatol; 2004 Mar; 122(3):621-30. PubMed ID: 15086544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Up-regulation of lysyl oxidase in spontaneous revertants of H-ras-transformed rat fibroblasts.
    Hajnal A; Klemenz R; Schäfer R
    Cancer Res; 1993 Oct; 53(19):4670-5. PubMed ID: 7691400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lysyl oxidase activity in the ocular tissues and the role of LOX in proliferative diabetic retinopathy and rhegmatogenous retinal detachment.
    Coral K; Angayarkanni N; Madhavan J; Bharathselvi M; Ramakrishnan S; Nandi K; Rishi P; Kasinathan N; Krishnakumar S
    Invest Ophthalmol Vis Sci; 2008 Nov; 49(11):4746-52. PubMed ID: 18566459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative functional study of the lysyl oxidase promoter in fibroblasts, Ras-transformed fibroblasts, myofibroblasts and smooth muscle cells.
    Reynaud C; Gleyzal C; Jourdan-Le Saux C; Sommer P
    Cell Mol Biol (Noisy-le-grand); 1999 Dec; 45(8):1237-47. PubMed ID: 10643973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of lysyl oxidase is correlated with lymph node metastasis and poor prognosis in esophageal squamous cell carcinoma.
    Sakai M; Kato H; Sano A; Tanaka N; Inose T; Kimura H; Sohda M; Nakajima M; Kuwano H
    Ann Surg Oncol; 2009 Sep; 16(9):2494-501. PubMed ID: 19526206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.